Table 7.
Final Study Visit Classification (%) | ||||
---|---|---|---|---|
Treatment Group Baseline Classificationa | Normal | Elevated | Stage 1 HTN | Stage 2 HTN |
Oral TU, N = 162b | ||||
Normal (22%) | 12 | 5 | 4 | 1 |
Elevated (13%) | 3 | 3 | 4 | 3 |
Stage 1 HTN (51%) | 5 | 6 | 21 | 19 |
Stage 2 HTN (14%) | 1 | 4 | 5 | 4 |
Topical T, N = 54b | ||||
Normal (41%) | 13 | 3 | 11 | 2 |
Elevated (13%) | 2 | 4 | 6 | 2 |
Stage 1 HTN (37%) | 6 | 4 | 17 | 11 |
Stage 2 HTN (3%) | 2 | 2 | 0 | 6 |
Abbreviations: dBP, diastolic blood pressure; sBP, systolic blood pressure.
aNormal sBP <120 mm Hg and dBP <80 mm Hg; elevated sBP 120–129 mm Hg and dBP <80 mmHg; Stage 1 sBP 130–139 mm Hg or dBP 80–89 mm Hg; and Stage 2 sBP ≥140 or dBP ≥ 90 mmHg.
bFour patients in the JATENZO group and 1 subject in Axiron group did not have follow up blood pressure.